AngioSoma Focusing on Development of Coating for Metal Stents
27. Mai 2020 10:42 ET
|
AngioSoma, Inc.
Houston, TX, May 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company is focusing on development and...
AngioSoma Continues to Liquidate Debt
21. April 2020 09:53 ET
|
AngioSoma, Inc.
Houston, TX, April 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced that holders of the Company's 12% unsecured convertible...
AngioSoma Moving Forward With Exciting New Products
09. März 2020 11:10 ET
|
AngioSoma, Inc.
Houston, TX, March 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced creating an innovative marketing strategy for its 15...
AngioSoma Announces Trademark Allowed for Muscles4U
22. Januar 2020 09:30 ET
|
AngioSoma, Inc.
Houston, TX, Jan. 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that we have received official notice of allowance...
Litigation Settlement Agreement Finished
13. Januar 2020 12:01 ET
|
AngioSoma, Inc.
Houston, TX, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) founding Director and Chief Executive Officer, Alex Blankenship,...
AngioSoma Explains History of Muscles4U.com
08. Januar 2020 10:46 ET
|
AngioSoma, Inc.
Houston, TX, Jan. 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN). I have worked in the Intensive care unit as well as the cardiac unit, body builder and single mom with...
AngioSoma Developing Male Enhancement Supplement
06. Januar 2020 11:22 ET
|
AngioSoma, Inc.
HOUSTON, TX, Jan. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced development of Full Salute™, a male ED (erectile...
AngioSoma Reacquires $11,600,000 Series A Preferred
16. Dezember 2019 11:56 ET
|
AngioSoma, Inc.
Houston, TX, Dec. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced reacquisition and cancellation of 100% of the Company's...
AngioSoma has Repaid $469,000 of Notes
20. November 2019 10:07 ET
|
AngioSoma, Inc.
Houston, TX, Nov. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced that holders of the Company's 12% unsecured convertible...
AngioSoma Confirms Status of Voting Control
20. August 2019 11:53 ET
|
AngioSoma, Inc.
Houston, TX , Aug. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) announced today the Company has filed an amendment to its Form 10-K for the fiscal year ended...